Table 1 Basic information statistics of subjects
Item | Control group (n=87) | Active group (n=87) | P |
|---|---|---|---|
Age (year) | 54.39±5.25 | 55.53±5.35 | 0.159 |
Gender (n/%) | 0.879 | ||
Male | 44(50.57) | 43(49.43) | |
Female | 43(49.43) | 44(50.57) | |
BMI (kg/m2) | 25.06±2.03 | 24.87±1.74 | 0.551 |
Type of lesion (n/%) | 0.376 | ||
Instability | 59(67.82) | 56(64.37) | |
Non-st-segment elevation | 20(22.99) | 17(19.54) | |
St-segment elevation | 8(9.19) | 14(16.09) | |
Comorbidity (n/%) | 0.935 | ||
Hypertension | 28(32.18) | 26(29.89) | |
Diabetes | 10(11.49) | 11(12.64) | |
Hyperlipidemias | 39(44.83) | 40(45.98) | |
SBP (mmHg) | 122.52±26.28 | 127.44±27.29 | 0.227 |
DBP (mmHg) | 62.60±15.73 | 66.45±13.73 | 0.087 |
TG (mmol/L) | 1.12±0.26 | 1.19±0.25 | 0.089 |
TC (mmol/L) | 5.79±1.60 | 5.87±1.66 | 0.735 |
HDL-C (mmol/L) | 1.39±0.46 | 1.31±0.31 | 0.171 |
LDL-C (mmol/L) | 2.78±1.12 | 2.94±1.09 | 0.345 |
FBG (mmol/L) | 6.36±2.74 | 6.97±2.64 | 0.142 |
Uric acid (μmol/L) | 375.39±101.14 | 385.65±106.46 | 0.515 |
Hemoglobin (g/L) | 130.63±21.23 | 129.61±20.61 | 0.749 |
Albumin (g/L) | 38.17±1.89 | 38.03±2.19 | 0.679 |
Procedural characteristics | |||
FMC-to-balloon | 153.74±51.05 | 160.99±48.32 | 0.337 |
Door-to-balloon | 123.98±42.77 | 134.33±40.67 | 0.103 |
Medications | |||
Beta-blocker | 18(20.69) | 16(18.39) | 0.702 |
Calcium-blocker | 7(8.04) | 10(11.49) | 0.444 |
Aspirin | 87(100) | 87(100) | – |
Clopidogrel | 87(100) | 87(100) | – |
ACEI/ARB | 25(28.74) | 23(26.43) | 0.734 |